At the time of writing, Pacific Biosciences of California Inc [PACB] stock is trading at $1.59, down -1.85%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The PACB shares have gain 13.57% over the last week, with a monthly amount glided 32.50%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pacific Biosciences of California Inc [NASDAQ: PACB] stock has seen the most recent analyst activity on November 11, 2024, when UBS downgraded its rating to a Neutral. On April 22, 2024, downgrade downgraded it’s rating to Neutral. Goldman downgraded its rating to a Neutral and decreased its price target to $2.50 on April 18, 2024. Stephens initiated its recommendation with a Overweight and recommended $11 as its price target on December 14, 2023. In a note dated December 13, 2023, Wolfe Research initiated an Peer Perform rating.
For the past year, the stock price of Pacific Biosciences of California Inc fluctuated between $0.85 and $2.72. Currently, Wall Street analysts expect the stock to reach $1.6 within the next 12 months. Pacific Biosciences of California Inc [NASDAQ: PACB] shares were valued at $1.59 at the most recent close of the market. An investor can expect a potential return of 0.63% based on the average PACB price forecast.
Analyzing the PACB fundamentals
According to Pacific Biosciences of California Inc [NASDAQ:PACB], the company’s sales were 156.11M for trailing twelve months, which represents an 10.42% jump. Gross Profit Margin for this corporation currently stands at -2.11% with Operating Profit Margin at -4.25%, Pretax Profit Margin comes in at -3.37%, and Net Profit Margin reading is -3.37%. To continue investigating profitability, this company’s Return on Assets is posted at -0.64, Equity is -1.89 and Total Capital is -0.87. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of11.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Pacific Biosciences of California Inc [NASDAQ:PACB] has a current ratio of 6.92. Further, the Quick Ratio stands at 6.02, while the Cash Ratio is 0.92. Considering the valuation of this stock, the price to sales ratio is 3.06, the price to book ratio is 7.77.
Transactions by insiders
Recent insider trading involved Van Oene Mark, that happened on Aug 18 ’25 when 26836.0 shares were sold. Officer, MARK VAN OENE completed a deal on Aug 18 ’25 to buy 26836.0 shares. Meanwhile, Farmer Michele sold 5195.0 shares on May 19 ’25.
